Motif Neurotech
[PRIVATE]Service & Cobot Robotics · HQ: Houston, Texas · Est. 2022 · 1 model registered · 2 deployments
As of Sep 2026, DEPLOY verifies Motif Neurotech: 1 model, 2 deployments across 2 regions, $18.8M raised. 1 source back the record.
Ownership
PRIVATE
Capital / Funding
$18.8M
Headquarters
Houston, Texas
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its Motif BCI XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.
Clean safety record across 2 verified deployments. Limited public visibility and press coverage relative to peers.
Key Facts
Safety & Regulatory Posture
No incidents on record for Motif Neurotech.
Leadership & Founders
Current Program Leadership & Executives
Co-founder
CEO & Co-founder
Founding Team
cofounder · founded 2023-01-01
cofounder · no longer at company
Partnerships & Commercial Deployments
Operator Customers & Fleet Integrators
Platform Models
Deployments
Sectors & Applications
FAQ
What is Motif Neurotech?
Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its Motif BCI XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.
What does Motif Neurotech make?
Motif Neurotech has 1 robot model on the DEPLOY registry: Motif BCI (Motif Neurotech builds physical robots).
Is Motif Neurotech publicly traded?
No. Motif Neurotech is privately held and not publicly traded, per the DEPLOY registry.
Who competes with Motif Neurotech?
On the DEPLOY registry, peer companies to Motif Neurotech building in the same form factors include Google, Samsung Electronics, Butterfly Network, Abbott.
Who is the CEO of Motif Neurotech?
Jacob Robinson is the ceo of Motif Neurotech, per the DEPLOY registry.
How can I invest in Motif Neurotech?
Motif Neurotech is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $19M in disclosed funding.
Where is Motif Neurotech headquartered?
Motif Neurotech is headquartered in Houston, Texas, USA.
How much funding has Motif Neurotech raised?
Motif Neurotech has raised approximately $19M in disclosed funding on record in the DEPLOY registry.
Who owns Motif Neurotech?
Motif Neurotech is privately held and venture-backed ($19M raised); ownership sits with its founders and private investors.
Where does Motif Neurotech operate robots?
Motif Neurotech operates 2 verified deployments, including at United States (multiple hotel chains), Germany, Europe.
How many robots has Motif Neurotech deployed?
DEPLOY has 2 verified Motif Neurotech deployments on record at sites including United States (multiple hotel chains), Germany, Europe. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is Motif Neurotech a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Motif Neurotech ranks in roughly the top 56% of companies tracked by the registry.
When was Motif Neurotech founded?
Motif Neurotech was founded in 2022.
Is Motif Neurotech safe?
Motif Neurotech has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.